Aernoud Fiolet

137 Colchicine in Patients with Chronic Coronary Disease (17) Department of Cardiology, Amphia, Breda, The Netherlands (18) Department of Cardiology, Spaarne Hospital, Haarlem and Hoofddorp, The Netherlands (19) Department of Cardiology, Green Heart Hospital, Gouda, The Netherlands (20) Department of Cardiology, Fiona Stanley Hospital, Murdoch, Australia (21) Department of Internal Medicine, Northwest Clinics, Alkmaar, The Netherlands (22) Faculty of Health and Medical Sciences, The University of Western Australia, Perth, Australia (23) Department of Neurology, Sir Charles Gairdner Hospital, Perth, Australia (24) School of Population and Global Health, University of Western Australia, Perth, Australia. (25) Department of Cardiology, Amsterdam UMC, Amsterdam, The Netherlands (26) Cardialysis BV, Rotterdam, The Netherlands (27) Harry Perkins Institute of Medical Research, Nedlands, Australia LoDoCo2 Trial Organization Steering Committee Members Stefan M. Nidorf, MD MBBS FRACP Arend Mosterd, MD PhD FESC John W. Eikelboom, MD MBBS FRCPC Jan H. Cornel, MD PhD FESC Peter L. Thompson, MD MBBS FRACP Aernoud T.L. Fiolet, MD (non-voting) Astrid Schut, MSc (non-voting) Jan G.P. Tijssen, PhD FESC (non-voting) End Point Adjudication Committee Graeme J. Hankey, MBBS MD (Co-chair) Marco Alings, MD PhD FESC (Co-chair) Chris Judkins, MBBS MClinRes PhD FRACP Maurits Dirksen, MD PhD Dirk Lok, MD PhD Willem A. Bax, MD PhD L. Jaap Kappelle, MD PhD Data Safety Monitoring Board Freek W.A. Verheugt, MD PhD (Chair) Brendan McQuillan, MD (Vice-chair) Kevin Murray, PhD (Statistician)